Borosil Targets FY27 Solar EBITDA Gain Amid Hydra Headwinds

Borosil Limited — Q4 FY26 Earnings Conference Call (held May 22, 2026)

1. Overall Tone of Management: Neutral (leaning Optimistic)

• Management acknowledges multiple near-term headwinds: “BIS order… supply chain challenges” impacting Hydra “revenue and margins” and “West Asia crisis… LPG… force majeure” affecting Q4 operations.
• Despite this, they repeatedly emphasize structural growth and continued investment: “we are not stopping our growth and expansion plans” and “fully… long-term growth trajectory… will continue unabated.”
• Guidance is mostly qualitative, with confidence in medium-term targets (e.g., EBITDA margin), but limited hard near-term commitments.

2. Key Themes from Management Commentary

• Hydra category disruption (core drag):
• Hydra bottle sales pressured due to BIS/QCO implementation and resulting supply chain constraints; management links margin pressure to “lower sales of Hydra without… reverse operating leverage.”
• They are building in-house vacuum-insulated stainless steel bottle capacity (Stylenest India) to restore compliance and supply.
• Glassware margin pressure from external cost/competition:
• Management cites China dumping/overcapacity as a persistent margin irritant.
• Also cites gas/input cost increases and lagged pricing actions: “price increase… lag impact.”
• Energy cost optimization via solar + battery:
• Solar expansion (20 MWp + BESS) expected to reduce power cost; management quantifies EBITDA benefit (see Guidance).
• Opalware demand is “muted” but capacity is high:
• Opalware utilization described as ~90–95%, but management expects muted growth for “the next year or so” and is prioritizing debottlenecking over major capex.
• Ongoing capex pipeline to strengthen Make-in-India and supply resilience:
• Vacuum-insulated bottle plant (3 lines; 2 by end of Q1 FY27, 3rd by end of Q2 FY27).
• Additional glass furnace capacity expansion (25 → 32 tonnes/day) and Bharuch outsourced glassware facility (capex ~INR42 cr; by end of Q3 FY27).
• Medium-term profitability ambition:
• Reiterates targets for revenue growth and EBITDA margin in the medium term despite FY26 margin softness.

3. Q&A Analysis

Theme A: Margin pressure—glassware (gas costs, China dumping, pricing lag)

• Core question(s):
• Why did glassware gross/EBITDA margins remain lower vs Q4 FY25 despite ramp-up?
• Will margins remain under pressure while Indian gas prices stay high?
• Status/timeline of anti-dumping investigation (borosilicate vs soda-lime)?
• Management response:
• China dumping: “China is dumping… in virtually every category.”
• Input cost shock: “cost of gas… gone up… especially in Q4,” plus pricing lag.
• Anti-dumping: applies to borosilicate glass only; expected outcome in “6 to 9 months.”
• On gas differential: acknowledges China also rising but “may not… 2.5x” as in India; rupee depreciation helps imports but costs rose too.
• Notable signals / strength / evasiveness:
• Strong attribution to external factors (dumping + gas), but limited quantification of margin bridge.
• Anti-dumping timeline is relatively specific (6–9 months), which is a clearer commitment than most other near-term items.

Theme B: Cost savings from solar plant

• Core question(s):
• Expected FY27 EBITDA cost savings from solar plant.
• Management response:
• CFO: “estimated to be about INR28 crores at EBITDA level, for FY27.”
• Notable signals:
• Clear quantitative number—one of the few hard FY27 figures provided.

Theme C: Opalware outlook—utilization, capex, demand/margin

• Core question(s):
• Opalware utilization, capex plans, market outlook.
• Competitive intensity/pricing pressure and qualitative FY27 margin outlook.
• Management response:
• Utilization: “close to 100%… 90% to 95%.”
• Demand: “market has slowed down… demand growth has not been as robust.”
• Capex: no major capex (no third line); focus on debottlenecking and shifting attention to faster-growth categories.
• Competition: management disagrees with dealer view of aggressive pricing; says competition pressure is not the main issue—cost pressure is.
• Pricing pass-through: cost increases need “a couple of quarters… 1, maybe 2 quarters.”
• Notable signals / evasiveness:
• Provides a clear stance: muted growth for “next year or so,” and capex restraint in opalware.
• Margin guidance remains qualitative (short-run pressure possible due to gas/cost pass-through).

Theme D: Hydra inventory, working capital, and supply normalization

• Core question(s):
• Is Hydra inventory fully depleted after prior QCO/BIS stocking?
• Will inventory/working capital keep rising given Hydra sales weakness?
• Management response:
• Hydra inventory built last year is “more or less all depleted.”
• Inventory growth this year is driven by appliance inventory due to QCO timelines and by producing more glassware due to furnace efficiency.
• Expects inventory “stop… hopefully this year itself” and reversal from next year.
• Notable signals:
• Acknowledges two consecutive years of inventory growth but frames it as one-off / policy-driven and expects normalization.

Theme E: Capex and funding (FY27 capex, debt stance)

• Core question(s):
• FY27 capex numbers; whether additional capex in appliances/glassware.
• Debt strategy given capex and prior caution.
• Management response:
• FY27 capex: “about INR90 plus crores” (earlier stated) and later “INR110 crores… broadly.”
• Maintenance capex: “INR20–25 crores a year.”
• Debt: management says they’re “very cautious,” operating cash flow (~INR120 cr) supports funding; short-term debt may rise but “no challenge.”
• Notable signals / evasiveness:
• Capex is given as ranges/broad numbers, not a strict guidance.
• Debt answer is reassuring but still timing-dependent (“if there’s some timing… may go up”).

4. Guidance / Outlook

Explicit guidance (quantitative)

• FY27 solar savings (EBITDA level): “estimated to be about INR28 crores.”
• FY27 capex (broad): “INR110 crores… broadly” (with maintenance capex ~INR20–25 cr/year).
• Medium-term targets (qualitative but with numbers):
• Revenue growth: “enhancing the revenue by 15% to 20% year-on-year.”
• EBITDA margin: “achieving EBITDA of closer to 20-odd percent in the medium term.”

Implicit signals (qualitative)

• Hydra: challenges are framed as short-term, with expectation that supply normalization will improve after new plant lines come online (2 lines by end of Q1 FY27; 3rd by end of Q2 FY27).
• Opalware: “muted growth” expected for “the next year or so,” with no major capex beyond debottlenecking.
• Glassware: growth depends on demand; supply chain capacity is not the constraint due to inventory and planned capacity additions.
• Margins: near-term margin pressure likely persists due to gas costs and China dumping, with cost pass-through lag of “1–2 quarters.”

5. Standout Statements (direct / revealing)

• Hydra as the margin/revenue culprit: operating EBITDA margin down due to “lower sales of Hydra without… reverse operating leverage.”
• China dumping explicitly blamed for margin pressure: “China is dumping on virtually in every category.”
• Solar savings quantified: “estimated to be about INR28 crores at EBITDA level, for FY27.”
• Opalware growth outlook toned down: “for the next year or so, I think we are going to expect to see muted growth.”
• Anti-dumping timeline: “6 to 9 months.”
• Medium-term commitment despite FY26 being tough: “we are fully committed to enhancing the revenue by 15% to 20%… and achieving EBITDA of closer to 20-odd percent in the medium term.”
• Hydra inventory normalization claim: “Hydra inventory… is more or less all depleted.”
• Glassware demand vs supply framing: “growth only from a demand perspective… is what we have to look out for.”

6. Red Flags / Positive Signals

Red flags
– Margin pressure drivers are largely external (dumping, gas) → risk that they persist longer than management expects.
– Guidance is mostly medium-term; near-term (FY27) is supported by solar savings but no consolidated margin guidance.
– Inventory/working capital: management admits “2 years consecutive of inventory growth,” even if they expect reversal.
– Opalware narrative softening: “muted growth” and no major capex suggests upside may be limited near-term.

Positive signals
– Clear capex execution milestones for vacuum-insulated bottle lines (Q1 FY27 and Q2 FY27).
– Quantified FY27 EBITDA benefit from solar (INR28 cr).
– Anti-dumping timeline provided (6–9 months).
– Debt comfort supported by operating cash flow and internal accruals.

7. Historical Comparison & Consistency Analysis (vs prior 3 calls)

a. Change in Tone Over Time

• Q1 FY26 (Aug 2025): optimistic medium-term; acknowledged near-term softness; emphasized structural tailwinds (plastic-to-glass, health).
• Q2 FY26 (Nov 2025): still confident; but margin explanations increasingly tied to Made in India transition and Hydra/BIS impacts.
• Q3 FY26 (Feb 2026): still resilient; but Hydra supply constraints remained a dominant issue; management guided toward “low-20s” EBITDA margin.
• Q4 FY26 (May 2026): tone becomes more cautious on margins (EBITDA margin down to 15.1% FY26) and more explicit about external shocks (gas/LPG force majeure + China dumping).
• Classification shift: More cautious than earlier calls, especially on near-term margin trajectory and opalware growth.

b. Tracking Past Commitments vs Outcomes

• Hydra supply normalization / shelf recovery
• Past statement (Q3 FY26, Feb 2026): expected to be “over the worst of it” and “Q4 will be better than Q3” from a supply perspective.
• What happened by Q4 FY26: Hydra still described as substantially pressured; FY26 EBITDA margin fell (16.3% → 15.1%) and Hydra remains the key drag.
• Flag: ❌ Missed / delayed (improvement not enough to prevent margin compression).
• EBITDA margin path (“low-20s” target)
• Past statement (Q3 FY26, Feb 2026): “we should be in the low-20s… in the very short foreseeable future… this year… closer to 18%…”
• Outcome in FY26 (Q4 FY26 call): operating EBITDA margin 15.1% for FY26; no evidence that “low-20s” was reached.
• Flag: ❌ Not delivered (timing slipped materially).
• Opalware capex restraint
• Past statement (Q1 FY26, Aug 2025): opalware capacity not at 100%; planned de-bottlenecking and later decisions.
• Current (Q4 FY26): utilization 90–95%, but “not considering any major capex” and expects muted growth.
• Flag: ✅/⏳ Consistent (no major capex; narrative aligns).

c. Narrative Shifts

• Hydra remains central, but the explanation broadens:
• Earlier calls focused on BIS compliance + domestic sourcing ecosystem ramp-up.
• Current call adds West Asia crisis/LPG force majeure and China dumping as additional margin threats.
• Opalware story shifts from “refresh needed” to “muted growth for next year or so” with explicit capex restraint.
• Glassware margin story shifts from internal cost optimization to external competitive/cost shocks (dumping + gas).

d. Consistency & Credibility Signals

• Credibility: Medium-Low
• Repeated medium-term margin confidence (“low-20s”) did not materialize in FY26.
• Management provides plausible reasons (Hydra, gas, dumping), but the timing of margin recovery appears to have slipped.
• However, they do provide more concrete execution milestones (bottle plant lines, solar savings, anti-dumping timeline), which improves credibility on operational execution.

e. Evolution of Key Themes

• Demand / category mix: Glassware and opalware growth continues, but Hydra disruption dominates overall profitability.
• Direction: Stable-to-deteriorating for margins; stable growth in glassware/opals.
• Margins: Deteriorated vs prior year (16.3% → 15.1% FY26).
• Direction: Deteriorating in FY26.
• Make in India / compliance capex: Continues to expand.
• Direction: Improving/stable (more in-house manufacturing to reduce policy risk).
• External competitive pressure (China dumping): becomes more explicit in Q4 FY26.
• Direction: Worsening (or at least more acknowledged).

f. Additional Insights (cross-period intelligence)

• A risk that was previously framed as “supply constraints improving” (Hydra) appears to have persisted long enough to materially affect FY26 margins—suggesting either:
• ramp-up took longer than expected, or
• demand/shelf recovery was weaker than hoped, or
• cost/competitive pressures offset any operational gains.
• Management increasingly uses policy + external shock explanations, but provides fewer quantitative bridges for margin recovery—indicating uncertainty around the timing of normalization.